Melissa Pilewskie, MD
Clinical Associate Professor of Surgery and Ambulatory Care
Clinical Chief
[email protected]

Available to mentor
Melissa Pilewskie, MD
Clinical Associate Professor
  • About
  • Qualifications
  • Research Overview
  • Recent Publications
    • About

    My clinical interest focuses on the surgical care of breast cancer in patients and those with an increased risk for the development of breast cancer including populations with genetic predispositions or a diagnosis of a high-risk breast lesion.

    Qualifications
    • Fellow, Breast Surgery
      Memorial Sloan Kettering Cancer Center, New York, NY, 2013
    • Resident, General Surgery
      Northwestern University, Feinberg School of Medicine, 2012
    • Administrative Chief Resident
      Northwestern University, Feinberg School of Medicine, 2012
    • MD
      Ohio State University Hospital, Columbus, OH, 2007
    • BS, Biology
      University of Michigan, Ann Arbor, MI, 2002
    Research Overview

    My research focuses on two distinct areas impacting the care of our breast cancer patients:
    - Populations at increased breast cancer risk with an interest in novel strategies for risk reduction.
    - Axillary surgery de-escalation to maintain oncologic safety while minimizing surgical morbidity.

    Recent Publications See All Publications
    • Journal Article
      ACR Appropriateness Criteria® Imaging of Invasive Breast Cancer.
      Expert Panel on Breast Imaging , McDonald ES, Scheel JR, Lewin AA, Weinstein SP, Dodelzon K, Dogan BE, Fitzpatrick A, Kuzmiak CM, Newell MS, Paulis LV, Pilewskie M, Salkowski LR, Silva HC, Sharpe RE, Specht JM, Ulaner GA, Slanetz PJ. J Am Coll Radiol, 2024 Jun; 21 (6S): S168 - S202. DOI:10.1016/j.jacr.2024.02.021
      PMID: 38823943
    • Journal Article
      Abstract GS02-02: Are nodal ITCs after neoadjuvant chemotherapy an indication for axillary dissection? The OPBC05/EUBREAST-14R/ICARO study
      Montagna G, Laws A, Ferrucci M, Mrdutt M, Polidorio N, Sevilimedu V, Moo T-A, Barrio A, Boyle MK, Cabero FV, Cocco D, Corsi F, Crown A, Flanagan MR, Gulcelik MA, Hlavin C, Jelinska J, Karanlik H, Kesmodel S, Kuerer H, Küemmel S, Leo C, Menes T, Pilewskie M, Pislar N, Rocco N, Ryu JM, Soares L, Tausch C, Ugurlu MU, URBAN C, Bruele ABVD, Vorburger D, Wärnberg F, Weiss A, Williams A, Wong S, Woodward SG, Sun SX, Zhang JQ, Ziauddin MF, Cakmak GK, Bese N, Kühn T, Boughey J, King T, Ditsch N, Banys-Paluchowski M, Morrow M, Weber W. Cancer Research, 2024 May 2; 84 (9_Supplement): gs02-02-gs02-02 DOI:10.1158/1538-7445.sabcs23-gs02-02
    • Journal Article
      Abstract RF01-02: A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: evaluation of dermal safety, intra-mammary drug distribution, and biologic effects
      Lee O, Bazzi L, Xu Y, Pearson E, Wang M, Hosseini O, Akasha A, Choi J, Kocherginsky M, Benante K, Helland T, Mellgren G, Dimond E, Perloff M, Heckman-Stoddard B, Khan S, Karlan S, Pilewskie M. Cancer Research, 2024 May 2; 84 (9_Supplement): rf01-02-rf01-02 DOI:10.1158/1538-7445.sabcs23-rf01-02
    • Journal Article
      Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions.
      Laws A, Leonard S, Hershey E, Stokes S, Vincuilla J, Sharma E, Milliron K, Garber JE, Merajver SD, King TA, Pilewskie ML. Ann Surg Oncol, 2024 May; 31 (5): 3120 - 3127. DOI:10.1245/s10434-024-14947-0
      PMID: 38261128
    • Presentation
      How to treat high-risk injuries
      2024 Apr 12;
    • Presentation
      Surgical considerations after neoadjuvant therapy
      2024 Apr 12;
    • Presentation
      Breast cancer risk reduction: what's on the Horizon
      2024 Apr 11;
    • Presentation
      Lifestyle habits: what influences the risk of breast cancer
      2024 Apr 11;